Functional Role of miRNAs in the Progression of Breast Ductal Carcinoma in Situ-Reference-Cited by-同舟云学术

Functional Role of miRNAs in the Progression of Breast Ductal Carcinoma in Situ

Published:2019-05 Issue:5 Volume:189 Page:966-974
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Hannafon Bethany N.^ORCID,Ding Wei-Qun

Funder

National Institute of General Medical Sciences

Presbyterian Health Foundation

Oklahoma Center for the Advancement of Science and Technology

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference80 articles.

1. Breast cancer precursors revisited: molecular features and progression pathways;Lopez-Garcia;Histopathology,2010

2. NIH state-of-the-science conference statement: diagnosis and management of ductal carcinoma in situ (DCIS);Allegra;NIH Consens State Sci Statements,2009

3. Molecular portraits of human breast tumours;Perou;Nature,2000

4. Repeated observation of breast tumor subtypes in independent gene expression data sets;Sorlie;Proc Natl Acad Sci U S A,2003

5. Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer;Tamimi;Breast Cancer Res Treat,2012

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of microRNA-21 expression with breast cancer subtypes and its potential as an early biomarker;Pathology - Research and Practice;2024-02

2. miR-124-2, miR-92-A1 and miR-372 regulate differential gene expression in a mathematical model of the progression of ductal carcinoma in situ (DCIS) to microinvasive breast cancer (MIBC);2022 IEEE 4th International Conference on BioInspired Processing (BIP);2022-11-15

3. Review—Systematic Review on Electrochemical Biosensing of Breast Cancer miRNAs to Develop Alternative DCIS Diagnostic Tool;ECS Sensors Plus;2022-06-01

4. Methylation of p53-responsive oncosuppressive microRNA genes in hemoblastosis;Siberian journal of oncology;2022-05-08

5. miR-145, miR-205 and miR-451: potential tumor suppressors involved in the progression of in situ to invasive carcinoma of the breast;Breast Cancer;2022-04-22